Clinical Trial: Gypenosides Treatment for Optic Neuritis
Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Interventional
Official Title: Gypenosides Treatment for Optic Neuritis: a Randomised, Double-blind, Placebo-controlled Trial
Brief Summary: The purpose of this study is to determine whether gypenosides are neuroprotective in patients with acute optic neuritis.
Detailed Summary:
Sponsor: First Affiliated Hospital of Guangxi Medical University
Current Primary Outcome: Mean retinal nerve fibre layer thickness [ Time Frame: 6 months ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- Total macular volume [ Time Frame: 6 months ]
- Best corrected visual acuity [ Time Frame: 6 months ]
- Latency and amplitude of visual evoked potentials [ Time Frame: 6 months ]
- Mean visual field defect [ Time Frame: 6 months ]
- Number of participants with Adverse events [ Time Frame: Screening until end of study ]
Original Secondary Outcome:
Information By: First Affiliated Hospital of Guangxi Medical University
Dates:
Date Received: November 24, 2016
Date Started: February 4, 2017
Date Completion: December 31, 2019
Last Updated: March 22, 2017
Last Verified: March 2017
